2024 ICD-10-CM Diagnosis Code C22.7

Other specified carcinomas of liver

  • C22.7 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
  • The 2024 edition of ICD-10-CM C22.7 became effective on October 1, 2023.
  • This is the American ICD-10-CM version of C22.7 – other international versions of ICD-10 C22.7 may differ.

The following code(s) above C22.7 contain annotation back-references

 that may be applicable to C22.7:

  • C00-D49  Neoplasms
  • C15-C26  Malignant neoplasms of digestive organs
  • C22  Malignant neoplasm of liver and intrahepatic bile ducts

ICD-10-CM C22.7 is grouped within Diagnostic Related Group(s) (MS-DRG v41.0):

  • 435 Malignancy of hepatobiliary system or pancreas with mcc
  • 436 Malignancy of hepatobiliary system or pancreas with cc
  • 437 Malignancy of hepatobiliary system or pancreas without cc/mcc

Convert C22.7 to ICD-9-CMCode History

  • 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
  • 2017 (effective 10/1/2016): No change
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
  • 2021 (effective 10/1/2020): No change
  • 2022 (effective 10/1/2021): No change
  • 2023 (effective 10/1/2022): No change
  • 2024 (effective 10/1/2023): No change

Diagnosis Index entries containing back-references to C22.7: